Cromolyn Sodium (Cromoglicic Acid)

Subscribe to Selected New Research on Cromolyn Sodium

1685 relevant articles (178 outcomes, 281 trials/studies) found for this Drug

Description: A chromone complex that acts by inhibiting the release of chemical mediators from sensitized mast cells. It is used in the prophylactic treatment of both allergic and exercise-induced asthma, but does not affect an established asthmatic attack.

Also Known As:

Cromoglicic Acid; Intal; Nasalcrom; Opticrom; Sodium Cromoglycate; Aarane; Bicromat Spray; Cromoglycate; Cromoglycic Acid; Cromolyn; FPL-670; Lomudal; Nalcrom; Vicrom; Cromoglycate, Disodium; Cromoglycate, Sodium; FPL 670; FPL670; Disodium Cromoglycate; 4H-1-Benzopyran-2-carboxylic acid, 5,5'-((2-hydroxy-1,3-propanediyl)bis(oxy))bis(4-oxo-, disodium salt)

Relationship Network

Drug Context: Research Results

Experts

1.	König, P: 4 articles (03/2002 - 02/2000)
2.	van der Wouden, J C: 3 articles (01/2003 - 11/2000)
3.	de Jongste, J C: 3 articles (01/2003 - 11/2000)
4.	Korppi, Matti: 2 articles (06/2008 - 12/2005)
5.	Shen, Ning: 2 articles (01/2008 - 05/2007)
6.	Gan, Xiao-liang: 2 articles (01/2008 - 05/2007)
7.	Hei, Zi-qing: 2 articles (01/2008 - 05/2007)
8.	Miyatake, Akihiko: 2 articles (09/2007 - 06/2004)
9.	Hidari, Kazuya I P J: 2 articles (09/2007 - 06/2004)
10.	Suzuki, Yasuo: 2 articles (09/2007 - 06/2004)

Related Diseases

1.	Asthma (Bronchial Asthma) 03/01/2006 - "Significant between-period intervention differences showed improvement of clinical outcomes for children with severe asthma during the five years of sodium cromoglycate inhalation. " 01/01/1989 - "The results indicate that sodium cromoglycate administered by pressurized aerosol at a dose of 2 x 1 mg or 2 x 5 mg 4-times daily is effective in the treatment of asthma and suggest that the higher dose formulation may provide more rapid control of symptoms." 07/01/1999 - "CONCLUSION: The HFA formulation of cromolyn sodium MDI is a well-tolerated and effective treatment for asthma patients > or = 12 years old. " 07/01/1993 - "Disodium cromolyn is effective in preventing asthma, but its steroid sparing effect remains controversial. " 01/01/1987 - "Cromolyn is effective for controlling the symptoms of mild to moderate chronic asthma in 60 to 70 percent of patients. " Order ALL the reference details at left...
2.	Rhinitis 04/01/2002 - "Intranasal cromolyn has an excellent safety record, is available as an over-the-counter medication, and has been proved to be efficacious in patients with allergic rhinitis." 08/01/1984 - "3) Disodium cromoglycate is not universally effective in chronic rhinitis, perhaps in part because compliance with a prophylactic drug requiring insufflation four or six times daily may not be high. " 03/01/1977 - "A large-scale multicenter investigation was undertaken in 3 cities with comparable pollen seasons and atmospheric pollen concentrations in order to obtain more definite information about the safety and efficacy of cromolyn sodium in the treatment of pollen-induced seasonal rhinitis. " 06/01/1978 - "A controlled trial comparing sodium cromoglycate 2% nasal solution against placebo has demonstrated that in patients with severe perennial rhinitis sodium cromoglycate is clinically effective and also that gross histological changes in the nasal mucosa are reversed following treatment for eight weeks with this therapy." 11/01/1988 - "Nasal cromolyn is effective for many patients with allergic rhinitis, but its effect is variable and it is useful in severe allergic rhinitis." Order ALL the reference details at left...
3.	Allergic Conjunctivitis (Giant Papillary Conjunctivitis) 02/01/1988 - "Cromolyn sodium was found to be significantly more effective than placebo in treating the signs and symptoms of vernal keratoconjunctivitis (VKC). " 01/01/1992 - "One of the main objectives of any therapy is to reduce the frequency of dosage and the current study has been designed to investigate the efficacy of a 4% solution of Sodium Cromoglycate, used twice daily, versus a 2% solution used four times daily in seasonal allergic conjunctivitis. " 02/01/1982 - "Vernal keratoconjunctivitis (VKC) is usually considered as an allergic eye disorder of type I, and in most therapeutic trials it has been shown to yield to topical treatment with sodium cromoglycate. " 07/01/1981 - "Previous studies have shown the effectiveness of topical cromolyn solution in the treatment of allergic conjunctivitis. " 05/01/1979 - "A double-blind group comparative trial comparing Opticrom with a matching placebo, over a four-week period, in seasonal allergic conjunctivitis is reported. " Order ALL the reference details at left...
4.	Exercise-Induced Asthma (Asthma, Exercise Induced) 09/01/1996 - "Hypotonic disodium cromoglycate seems to be clinically effective for prevention of exercise-induced bronchospasm and treatment of asthmatic children." 09/01/1996 - "We conclude that the efficacy of hypotonic and isotonic disodium cromoglycate solutions is similar for protection against exercise-induced bronchospasm. " 01/01/1984 - "Eight patients with exercise-induced asthma participated in a single blind dose-duration study comparing the protective effect of inhaled sodium cromoglycate (SCG) in increasing concentrations from 2 to 40 g/l. " 09/01/1982 - "Ten patients with exercise-induced asthma participated in a single-blind dose-response study comparing the protective effect of inhaled sodium cromoglycate in increasing concentrations from 2 to 40 mg/ml. Saline was used as a control. " 09/01/1982 - "Dose-response study of sodium cromoglycate in exercise-induced asthma." Order ALL the reference details at left...
5.	Hypersensitivity (Allergy) 11/01/1998 - "Mast cell stabilizers such as sodium cromoglycate are both safe and effective and are commonly used in ocular allergy. " 03/01/1983 - "To study the effects of cromolyn sodium on the airway reactivity of asthmatics, we performed a randomized, double-blind, crossover study in which 11 atopic asthmatics inhaled 20 mg of cromolyn sodium or a matching placebo four times daily for 4 wk each, while in their allergy season. " 08/01/1980 - "Allergy to laboratory animals: epidemiologic, clinical, and physiologic aspects, and a trial of cromolyn in its management." 05/01/1979 - "If these are positive a diagnosis of 'barn allergy' should be considered and a trial of sodium cromoglycate be given." 01/01/1977 - "A therapeutic trial of disodium cromoglycate in gastrointestinal allergy." Order ALL the reference details at left...

Related Drugs and Biologics

1.	Cromolyn Sodium (Cromoglicic Acid)
2.	Nedocromil (Alocril)
3.	Beclomethasone (Beclometasone)
4.	Ketotifen (Ketotifene)
5.	Adrenal Cortex Hormones (Corticosteroids)
6.	Steroids
7.	lodoxamide ethyl (lodoxamide)
8.	Immunoglobulin E (IgE)
9.	Ipratropium (Ipratropium Bromide)
10.	Ophthalmic Solutions (Eye Drops)

Related Therapies and Procedures

1.	Drug Therapy (Chemotherapy)
2.	Immunotherapy
3.	Metered Dose Inhalers (Metered Dose Inhaler)
4.	Nebulizers and Vaporizers (Inhaler)
5.	Premedication

Best Treatments:
Research Summary Report
on Asthma

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.

Free Updates for 1 Year
All 2978 Outcomes
Top 200 Key Drugs and Biologics
Top 50 Key Therapies and Procedures
Detailed History Charts
Full Research Reference Details
Sample PDF Report on Psoriasis >>

Price:

$24.00 & Delivery via PDF download
updates for 1 year

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License Details >>

Price:

$490.00 access via web interface
1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m"
1 year subscription

Proceed to Checkout >>